[ Price : $8.95]
FDA approves Vertex Pharmaceuticals Kalydeco (ivacaftor) for use in certain children with cystic fibrosis ages four months to less...[ Price : $8.95]
FDA approves GlaxoSmithKlines Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome...[ Price : $8.95]
FDA grants RemeGen a Breakthrough Therapy designation for disitamab vedotin (RC48), an anti-HER2 antibody drug conjugate for secon...[ Price : $8.95]
Federal Register notice: FDA proposes to withdraw approval of five ANDAs because the application holders have repeatedly failed to...[ Price : $8.95]
After FDA commissioner Stephen Hahn assured Congress that FDAs review and approval/authorization of a Covid-19 vaccine would be ba...[ Price : $8.95]
FDA releases the FDA-483 with three observations from an inspection at Front Range Laboratories.[ Price : $8.95]
FDA announces a two-day (10/15-16) public Webinar on New Approaches for an Integrated Nonclinical-Clinical QT/Proarrhythmic Risk A...[ Price : $8.95]
FDA says it now recommends that people in seven high-risk categories refrain from exposure to dental mercury amalgam when possible...